Avalon GloboCare Up 12% After GE Healthcare Partnership
July 23 2019 - 10:10AM
Dow Jones News
By Chris Wack
Shares of Avalon GloboCare Corp. (AVCO) rose 12% to $2.35 after
the company announced a strategic partnership with GE
Healthcare.
The clinical-stage global developer of cell-based technologies
and therapeutics said the partnership will accelerate Avalon's
standardization, automation and bio-production for clinical-grade
Chimeric Antigen Receptor cells and other immune-effector cells for
cellular immunotherapy.
Both Avalon and GE Healthcare will strategically establish
automated and standardized GMP cell production capabilities. Avalon
will be given access to GE Healthcare's cell processing expertise
and products in the form of FlexFactory Cell Therapy platform,
FastTrak process development and training services.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
July 23, 2019 09:55 ET (13:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
General Electric (NYSE:GE)
Historical Stock Chart
From Feb 2024 to Mar 2024
General Electric (NYSE:GE)
Historical Stock Chart
From Mar 2023 to Mar 2024